DelveInsight's“ Diarrhea Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Diarrhea pipeline landscape. It covers the Diarrhea Pipeline ...

Experts strategized how to bolster troop combat readiness in Djibouti through better diarrhea treatment during a recent visit by medical researchers to Camp Lemonnier.

Trodelvy showed fewer severe side effects, such as neutropenia and diarrhea, compared to chemotherapy in untreated TNBC ...

Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA’s June deadline – 51 dogs ...

Raw oysters have been linked to an ongoing Salmonella outbreak, the CDC said on Tuesday, infecting 64 people across 22 states ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The Wegovy pill is expected to be available within weeks. Experts say oral pills could expand access and reduce costs for ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side ...

Following the recent approval of nerandomilast tablets for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, the FDA has approved the medication for progressive pulmonary fibrosis as ...